HKSE - Delayed Quote HKD
Shanghai Henlius Biotech, Inc. (2696.HK)
At close: October 21 at 4:08 PM GMT+8
Research Analysis
Revenue vs. Earnings
Revenue 1.37B
Earnings 193.15M
Analyst Price Targets
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 2 |
| Avg. Estimate | 0 | 0 | 1.13 | 1.35 |
| Low Estimate | 0 | 0 | 1.11 | 1.22 |
| High Estimate | 0 | 0 | 1.16 | 1.49 |
| Year Ago EPS | -- | -- | 1 | 1.13 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | -- | 2 | 2 |
| Avg. Estimate | 6.18B | -- | 6.18B | 6.53B |
| Low Estimate | 6.13B | -- | 6.13B | 6.46B |
| High Estimate | 6.24B | -- | 6.24B | 6.6B |
| Year Ago Sales | 5.39B | -- | 5.39B | 6.18B |
| Sales Growth (year/est) | 14.60% | -- | 14.60% | 5.60% |
Earnings History
| CURRENCY IN USD | |
|---|---|
| EPS Est. | -- |
| EPS Actual | -- |
| Difference | -- |
| Surprise % | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 1.13 | 1.35 |
| 7 Days Ago | 0 | 0 | 1.13 | 1.36 |
| 30 Days Ago | 0 | 0 | 1.05 | 1.26 |
| 60 Days Ago | 0 | 0 | 1.16 | 1.39 |
| 90 Days Ago | 0 | 0 | 1.23 | 1.49 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | 2696.HK | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 3.60% |
| Next Qtr. | -- | -- | -- | 7.90% |
| Current Year | 13.00% | -- | -- | 2.50% |
| Next Year | 19.50% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.87% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Related Tickers
2142.HK HBM Holdings Limited
1.270
+0.79%
2511.HK HighTide Therapeutics Inc
1.070
-4.46%
SIGHT.PA GenSight Biologics S.A.
0.3425
-1.15%
1548.HK Genscript Biotech Corporation
11.800
-2.48%
1801.HK Innovent Biologics, Inc.
45.550
-1.94%
2269.HK WuXi Biologics (Cayman) Inc.
16.340
-0.97%
QURE uniQure N.V.
6.60
+2.80%
ALNY Alnylam Pharmaceuticals, Inc.
292.01
-1.32%
WVE Wave Life Sciences Ltd.
15.11
-1.31%
NVAX Novavax, Inc.
10.14
-0.39%